AAA Accelerator and Algatek Introduce Infinity Blue Coffee

Seagriculture EU 2024
Infinity Blue

Algatek and the AAA Accelerator Group launch their new coffee beans called “Infinity Blue.”

The AAA Accelerator Group Europe AG, in Switzerland, and its biotech subsidiary Algatek Asturias, S.L., of Teverga Asturias Spain, have announced the launch of its new coffee beans called “Infinity Blue” — the newest most innovative coffee product of the Kafelina line that Algatek bills as the latest healthy coffee option on the market.

The coffee bean production process for Infinity Blue has been registered for patent for coating the coffee beans with a soluble protein extracted from spirulina yielding a blue coffee bean that gives the consumer proteins not present in other coffee drinks. The coating also protects the coffee bean flavor, keeping the beans fresh for longer and locking in a premium coffee taste. Everyday coffee drinkers will get nutrients and protein to boost their immune systems.

The Swiss company and its biotech subsidiary have developed a proprietary patented algae photobioreactor technology that they claim accelerates growth and boosts yield efficiency. The closed system monitors and manipulates a wide range of cultivation parameters, and then replicates those conditions at commercial volume in full compliance with food and pharmaceutical production and safety standards.

Algatek S.l. is currently selling Infinity Blue through Xellis in Luxembourg, Salling Group supermarkets in Denmark, Mas y mas Supermarkets in Spain, Ocean Blue Planet in Dubai, and the Espresso Capsule Company in the UK.

All rights reserved. Permission required to reprint articles in their entirety. Must include copyright statement and live hyperlinks. Contact editorial@algaeplanet.com. Algae Planet accepts unsolicited manuscripts for consideration, and takes no responsibility for the validity of claims made in submitted editorial.

Seagriculture USA 2024
AlgaeMetrics
Contact Phil Ganz

Subscribe

Breaking-News

  • June 14, 2024: Engineers at the University of California San Diego have developed microscopic robots, known as microrobots, capable of swimming through the lungs to deliver cancer-fighting medication directly to metastatic tumors. This approach has shown promise in mice, where it inhibited the growth and spread of tumors that had metastasized to the lungs, thereby boosting survival rates compared to control treatments. READ MORE...
  • June 12, 2024: The PROTEUS consortium of 11 international partners, funded by the Circular Bio-Based Europe Joint Undertaking, intends to establish the first industrial-scale biorefinery for brown seaweeds. This facility will enhance sustainable production of bio-based ingredients from Laminaria hyperborea, an untapped European renewable resource, meeting global demand in food, feed, personal care, and industrial sectors. READ MORE...
  • June 10, 2024: University of North Carolina at Chapel Hill researcher Hans W. Paerl, PhD, will join researchers at the University of Michigan for a $6.5 million, five-year federal grant to host a center for studying links between climate change, harmful algal blooms and human health. READ MORE...
  • June 7, 2024: Three freshwater microalgal species: Chlorella protothecoides, Micractinium sp., and Scenedesmus obliquus were cultured under a static magnetic field and its influence on the accumulation of biomolecules (lipids, proteins, carbohydrates) and biomass production have been evaluated. READ MORE...

Algae Europe 2024

A Beginner’s Guide